Denali Therapeutics Inc.

DNLI ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2017

Total Assets: $486.7M

Liabilities Breakdown FY2017

Total Liabilities: $20.9M